A phase I, single centre, open study to assess the pharmacokinetic profile and safety of a 100 mg clindamycin hydrochloride vaginal insert (CHVI) in healthy females.

Trial Profile

A phase I, single centre, open study to assess the pharmacokinetic profile and safety of a 100 mg clindamycin hydrochloride vaginal insert (CHVI) in healthy females.

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Oct 2014

At a glance

  • Drugs Clindamycin (Primary)
  • Indications Bacterial vaginosis
  • Focus Pharmacokinetics
  • Sponsors Controlled Therapeutics (Scotland)
  • Most Recent Events

    • 20 Sep 2011 Actual end date (Nov 2007 ) added as reported by ClinicalTrials.gov.
    • 17 Oct 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top